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The final step in the diagnostic process to establish a diag-
nosis of brain death (BD) in a potential organ donor (POD)
with catastrophic brain injury is the apnea test (AT). The
whole brain death concept, which is adhered to in most
countries, dictates that apnea is the final and most definitive
proof of total loss of brain function including the brain stem.
This situation is then legally representative of a deceased
patient, in spite of intact cardiac function, which allows
subsequent organ procurement because this would not be
ethically and legally acceptable in a patient considered still
‘‘alive’’. However, the apnea test, which aims to establish
apnea in spite of a significant rise of CO2 in the blood (which
would always trigger respiratory effort in neurologically
intact persons without medical suppression of breathing),
cannot always be completed due to the fact that hemody-
namic instability and/or desaturation may ensue due to
interruption of mechanical ventilation and inadequate oxy-
genation in apnea. To minimize the risk of hypoxia and the
subsequent need for interruption of the AT, a common
practice is to apply the oxygen-diffusion method (i.e. apneic
oxygenation) during the apnea period, after adequate pre-
oxygenation. This method has a very high success rate with
very low percentages of desaturations that require abortion
of the AT [1].
In a large series of patients (n = 142) tested for brain
death and undergoing ATs, including the largest cohort of
patients on veno-arterial extra-corporeal membrane oxy-
genators (VA-ECMO, n = 25) reported to date, Giani
et al. recently evaluated the success rate of recruitment
maneuvers before, and the maintenance of positive-end
expiratory pressure (PEEP) during, the apnea after sepa-
ration from the ventilator [2]. Of note, Italian legislation
requires a total of three ATs for BD diagnosis. During the
AT, PEEP was established with an AMBU bag with an
adjustable PEEP valve connected with 8 L/min of oxy-
gen. The main findings of this investigation were that AT
abortions did not occur with this strategy in non-ECMO
patients (except for one patient with hemodynamic
instability not related to the AT) and that AT in patients
on VA-ECMO was feasible in all included patients. In
almost all patients, hemodynamic stability was main-
tained during the AT. Of note, however, hypoxia, defined
as pO2\40 mmHg (5.3 kPa), occurred in 2.7 % in non-
ECMO and in 6.4 % in ECMO patients (and in 11.1 vs.
4.8 % of all patients with vs. without baseline hypoxia
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defined as a paO2/FiO2 ratio\200 mm Hg). The authors
did not provide data on oxygen saturation levels.
An important question is whether and how the results of
this study may impact our clinical practice of determination
of BD, especially regarding the AT. To address this question,
several issues need to be scrutinized. First, the data do not
suggest that using recruitment and PEEP in AT are superior
to previously published results for ATs using the oxygen-
diffusion method, since abortion occurred in one study using
this method in 4.8 % (10/207) of the patients in whom
hypoxia was the main reason for AT abortion [1]. These
hypoxia rates seem comparable to the study by Giani et al.,
although hypoxia was not precisely defined. Therefore, one
is left wondering whether the recruitment and PEEP appli-
cation is worthwhile. Second, exact AT abortion criteria
were not given by the authors, and the data provided even
suggest that some level of hypoxia was accepted, whereas
hypoxia defined as oxygen saturation of\90 % may be an
abortion criterion for the AT in other countries, for instance
in the Netherlands [3]. In that sense, comparability of studies
on abortion rates is seriously hampered when exact
definitions of aborting criteria are not provided, as was the
case in this study. Third, it is not entirely clear why the
authors chose to apply recruitment and PEEP in all patients,
because most patients without pulmonary dysfunction will
easily pass an AT with pre-oxygenation and subsequent
apneic oxygen-diffusion method. Recruitment and PEEP
application may theoretically even bear some risks in such
patients, for instance by causing pneumothorax, although
this was reported not to be the case in this paper. However, it
feels more appropriate to select patients with pre-AT
hypoxia for recruitment and PEEP, instead of a ‘‘one-size-
fits-all’’ strategy. Furthermore, the data provided do not
allow conclusions on the comparative effectiveness of either
recruitment or PEEP since both were applied in all patients.
Fourth, although this is the largest published cohort on BD
patients on VA-ECMO to date, the study may not also be
applicable to patients with veno-venous ECMO, which may
be regarded as a limitation of the study. Finally, AT is just
one of the steps in BD diagnosis, and optimizing the AT may
not be sufficient to optimize the entire BD diagnostic process
(Fig. 1).
Two messages seem to stand out from the results pro-
vided: (1) recruitment and PEEP application before and
during AT seem quite safe, although the additive value of
this strategy compared with the apneic oxygen-diffusion
technique cannot be derived from this study, and (2) BD
testing including AT in VA-ECMO patients seems feasible,
rendering these patients suitable for organ procurement. For
clinical practice, intensivists may, based on these results, feel
more confident when they want to use recruitment and/or
PEEP for ATs in selected patients in whom desaturation
during an AT is anticipated or expected, or who are on VA-
ECMO. The authors are to be applauded for these clinically
relevant data that may help optimizing ATs for the decla-
ration of brain death. However, whether the strategy
described really contributes to increased numbers of organ
procurements remains to be established.
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Fig. 1 Barriers for successful completion of the apnea test to
establishing brain death diagnosis in patients with catastrophic
brain injury who are potential organ donors, and key issues in
management of these barriers. * In some countries chronic CO2
retention precludes the apnea test and alternative proof of brain
death is needed, e.g., absent cerebral circulation
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